Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.37 USD
Change Today -0.02 / -5.13%
Volume 5.0K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tyler M. Dylan-Hyde Ph.D., J.D.

Co-Founder, Chief Business Officer, Executive Vice President, General Counsel, Secretary and Director,Taxus Cardium Pharmaceuticals Group Inc.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Tyler M. Dylan-Hyde, Ph.D., JD is Co-Founder and has been Executive Vice President, General Counsel and Secretary of Cardium Therapeutics Inc., since its inception in December 2003, and as the Chief Business Officer since May 2005. Dr. Dylan-Hyde serves as the Chief Business Officer, Executive Vice President, Company Secretary and General Counsel of Tissue Repair Company, a subsidiary of Cardium Therapeutics Inc. He served as the Chief Business Officer, Executive ...

Read Full Background

Corporate Headquarters*

11750 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-436-1000
Fax: 858-436-1001

Board Members Memberships*

Chief Business Officer, Executive Vice President, Corporate Secretary, General Counsel and Director
Co-Founder, Chief Business Officer, Executive Vice President, General Counsel, Secretary and Director


University of California Berkeley
University of California - San Diego
McGill University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$192,966

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$192,966
Total Short Term Compensation$192,966
Total Calculated Compensation$346,876
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRXM:US $0.37 USD -0.02


Parker H. Petit Chairman and Chief Executive Officer
MiMedx Group, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAXUS CARDIUM PHARMACEUTICAL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at